Authors:
Exner, M
Thalhammer-Scherrer, R
Kudlacek, S
Simonitsch, I
Jager, U
Schwarzinger, I
Citation: M. Exner et al., Suspect cell convolutes in the bone marrow of a patient with renal cell carcinoma unmasked as atypical convolutes of hairy cells, LEUK LYMPH, 42(1-2), 2001, pp. 239-241
Authors:
Keil, F
Prinz, F
Kalhs, P
Lechner, K
Moser, K
Schwarzinger, I
Jager, U
Fonatsch, C
Worel, N
Mannhalter, C
Rabitsch, W
Loidolt, H
Schulenburg, A
Mitterbauer, M
Hocker, P
Greinix, HT
Citation: F. Keil et al., Treatment of leukemic relapse after allogeneic stem cell transplantation with cytotoreductive chemotherapy and/or immunotherapy or second transplants, LEUKEMIA, 15(3), 2001, pp. 355-361
Authors:
Selenko, N
Majdic, O
Draxler, S
Berer, A
Jager, U
Knapp, W
Stockl, J
Citation: N. Selenko et al., CD20 antibody (C2B8)-induced apoptosis of lymphoma cells promotes phagocytosis by dendritic cells and cross-priming of CD8(+) cytotoxic T cells, LEUKEMIA, 15(10), 2001, pp. 1619-1626
Citation: A. Falkenbach et U. Jager, Is chronic lymphocytic leukemia a contraindication for radon and thermotherapy? - A case report, WIEN KLIN W, 113(1-2), 2001, pp. 73-75
Authors:
Pirc-Danoewinata, H
Dauwerse, HG
Konig, M
Chudoba, I
Mitterbauer, M
Jager, U
Breuning, MH
Haas, OA
Citation: H. Pirc-danoewinata et al., CBFB/MYHII fusion in a patient with AML-M4Eo and cytogenetically normal chromosomes 16, GENE CHROM, 29(2), 2000, pp. 186-191
Authors:
Streubel, B
Valent, P
Jager, U
Edelhauser, M
Wandt, H
Wagner, T
Buchner, T
Lechner, K
Fonatsch, C
Citation: B. Streubel et al., Amplification of the MLL gene on double minutes, a homogeneously staining region, and ring chromosomes in five patients with acute myeloid leukemia or myelodysplastic syndrome, GENE CHROM, 27(4), 2000, pp. 380-386
Citation: G. Mavria et al., Generation of a high titre retroviral vector for endothelial cell-specificgene expression in vivo, GENE THER, 7(5), 2000, pp. 368-376
Authors:
Greinix, HT
Loidolt, H
Rabitsch, W
Schulenburg, A
Keil, F
Mitterbauer, M
Laczika, K
Lechner, K
Dieckmann, K
Fischer, G
Jager, U
Rosenmayr, A
Knobl, P
Schwarzinger, I
Hocker, P
Mannhalter, C
Hinterberger, W
Haas, OA
Fonatsch, C
Kalhs, P
Citation: Ht. Greinix et al., Excellent disease eradication by myeloablative therapy and stem-cell transplantation in patients with acute myelogenous leukemia, ANN HEMATOL, 79(4), 2000, pp. 206-213
Authors:
Konigsberg, R
Ackermann, J
Kaufmann, H
Zojer, N
Urbauer, E
Kromer, E
Jager, U
Gisslinger, H
Schreiber, S
Heinz, R
Ludwig, H
Huber, H
Drach, J
Citation: R. Konigsberg et al., Deletions of chromosome 13q in monoclonal gammopathy of undetermined significance, LEUKEMIA, 14(11), 2000, pp. 1975-1979
Authors:
Konigsberg, R
Zojer, N
Ackermann, J
Kromer, E
Kittler, H
Fritz, E
Kaufmann, H
Nosslinger, T
Riedl, L
Gisslinger, H
Jager, U
Simonitsch, I
Heinz, R
Ludwig, H
Huber, H
Drach, J
Citation: R. Konigsberg et al., Predictive role of interphase cytogenetics for survival of patients with multiple myeloma, J CL ONCOL, 18(4), 2000, pp. 804-812
Authors:
Exner, M
Thalhammer, R
Kapiotis, S
Mitterbauer, G
Knobl, P
Haas, OA
Jager, U
Schwarzinger, I
Citation: M. Exner et al., The "typical" immunophenotype of acute promyelocytic leukemia (APL-M3): Does it prove true for the M3-variant?, CYTOMETRY, 42(2), 2000, pp. 106-109
Authors:
Fureder, W
Streubel, B
Jordan, JH
Walchshofer, S
Wimazal, F
Jager, U
Geissler, K
Schwartz, LB
Chott, A
Lechner, K
Valent, P
Fonatsch, C
Citation: W. Fureder et al., Reciprocal translocation (3;5)(q26;q22) and possible BCHE gene involvementin an unusual myelogenous disorder with bath myeloproliferative and dysplastic features, CANC GENET, 121(2), 2000, pp. 133-138
Authors:
Geissler, K
Gisslinger, H
Knobl, P
Sperr, W
Valent, P
Dieckmann, K
Chott, A
Potter, R
Lechner, K
Jager, U
Citation: K. Geissler et al., Efficacy of standard treatment in patients with Hodgkin's disease - A single center experience, WIEN KLIN W, 112(14), 2000, pp. 624-628
Authors:
Wieser, R
Volz, A
Schnittger, S
Jager, U
Gruner, H
Meran, JG
Wimmer, K
Ziegler, A
Fonatsch, C
Citation: R. Wieser et al., Mapping of leukaemia-associated breakpoints in chromosome band 3q21 using a newly established PAC contig, BR J HAEM, 110(2), 2000, pp. 343-350
Authors:
Mitterbauer, G
Zimmer, C
Pirc-Danoewinata, H
Haas, OA
Hojas, S
Schwarzinger, I
Greinix, H
Jager, U
Lechner, K
Mannhalter, C
Citation: G. Mitterbauer et al., Monitoring of minimal residual disease in patients with MLL-AF6-positive acute myeloid leukaemia by reverse transcriptase polymerase chain reaction, BR J HAEM, 109(3), 2000, pp. 622-628
Authors:
Jager, U
Bocskor, S
Le, T
Mitterbauer, G
Bolz, I
Chott, A
Kneba, M
Mannhalter, C
Nadel, B
Citation: U. Jager et al., Follicular lymphomas' BCL-2/IgH junctions contain templated nucleotide insertions: novel insights into the mechanism of t(14;18) translocation, BLOOD, 95(11), 2000, pp. 3520-3529
Authors:
Wieser, R
Volz, A
Vinatzer, U
Gardiner, K
Jager, U
Mitterbauer, M
Ziegler, A
Fonatsch, C
Citation: R. Wieser et al., Transcription factor GATA-2 gene is located near 3q21 breakpoints in myeloid leukemia, BIOC BIOP R, 273(1), 2000, pp. 239-245
Authors:
Fiegl, M
Mitterbauer, G
Weltermann, A
Pirc-Danoewinata, H
Jager, U
Citation: M. Fiegl et al., Chronic myelogenous leukemia in chronic phase for 16 years: Ongoing hematological remission and late minor cytogenetic response under minimal interferon maintenance therapy, LEUK LYMPH, 35(3-4), 1999, pp. 409-413
Citation: U. Jager et al., Induction of complement attack on human cells by Gal(alpha 1,3)Gal xenoantigen expression as a gene therapy approach to cancer, GENE THER, 6(6), 1999, pp. 1073-1083
Authors:
Meidlinger, P
Knobl, P
Jager, U
Gisslinger, H
Pabinger, I
Weltermann, A
Lechner, K
Geissler, K
Citation: P. Meidlinger et al., Granulocyte colony-stimulating factor-supported combined immunosuppressivetherapy (antilymphocyte globulin, cyclosporine, and methylprednisolone) inpatients with aplastic anemia: tolerability, efficacy, and changes in the progenitor cell compartment, ANN HEMATOL, 78(7), 1999, pp. 299-304